News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Gold Price Prediction March 2026: Rally, Crash, or Record Highs?
CryptoNewsNet·2026/03/03 20:54
Polkadot Soars 2.3% to $1.555 — What’s Driving This Surge?
CryptoNewsNet·2026/03/03 20:54
Shift4 (FOUR) Shares Skyrocket, What You Need To Know
Finviz·2026/03/03 20:48
Viking (VIK) Stock Trades Up, Here Is Why
Finviz·2026/03/03 20:48
Rapid7 (RPD) Shares Skyrocket, What You Need To Know
Finviz·2026/03/03 20:48
Why Domo (DOMO) Stock Is Up Today
Finviz·2026/03/03 20:48
Why Acuity Brands (AYI) Shares Are Trading Lower Today
Finviz·2026/03/03 20:48
Tom Lee: Iran-Related Volatility Is A 'Risk Premium', But The Bottom Is Close
Finviz·2026/03/03 20:45
BitMine Buys Another 50,000+ ETH and Inches Toward Its 5% Target
BeInCrypto·2026/03/03 20:42
Trump's Maritime Insurance Order Sparks Relief Rally: 10 Stocks Moving
Finviz·2026/03/03 20:36
Flash
22:12
All three major U.S. stock indexes closed lower, while U.S. cybersecurity stocks strengthened.格隆汇 March 6｜The three major US stock indexes closed down collectively, with the Dow Jones falling 1.61%, the S&P 500 index down 0.57%, and the Nasdaq down 0.26%. Major technology stocks were mixed, with Microsoft rising over 1%, Nvidia, Netflix, Amazon, and Intel posting slight gains; Meta fell over 1%, while Apple, Tesla, and Google saw slight declines. US cybersecurity stocks strengthened, with Okta up 11%, CrowdStrike up over 4%, and Datadog up over 3%.
22:08
Simon Property Group announces completion of amendments, restatements, and extensions to existing credit arrangementsThe latest maturity date for this financing instrument has been set for June 30, 2030. It is worth noting that the agreement includes an optional renewal clause, allowing the company to further extend the term to June 30, 2031.
22:07
According to the latest public documents from the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Contineum Therapeutics Inc. has launched a new stock offering plan.The company plans to publicly offer its Class A common stock through the underwriter Leerink Partners, with a maximum fundraising scale of up to 100 million USD. This financing plan aims to provide funding support for the company's clinical-stage research and development projects, further advancing the development process of its drugs for the treatment of neurological diseases. Specific issuance terms, including the offering price, number of shares, and final fundraising scale, will be determined based on market conditions.